{
    "eid": "2-s2.0-85096998026",
    "title": "Bioengineering of virus-like particles for the prevention or treatment of allergic diseases",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pulmonary and Respiratory Medicine",
            "@code": "2740",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Allergen",
        "Autoantibodies",
        "Blocking antibodies",
        "CpG motif",
        "Nanoparticles"
    ],
    "authors": [
        "Phornsiri Pechsrichuang",
        "Supannika Namwongnao",
        "Alain Jacquet"
    ],
    "citedby-count": 4,
    "ref-count": 70,
    "ref-list": [
        "Barrier epithelial cells and the control of type 2 immunity",
        "Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers",
        "Allergen extracts for in vivo diagnosis and treatment of allergy: is there a future?",
        "Recent developments and highlights in allergen immunotherapy",
        "Evolution of immune responses in food immunotherapy",
        "Molecular approaches to allergen-specific immunotherapy: Are we so far from clinical implementation?",
        "Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement",
        "Immunological basis for enhanced immunity of nanoparticle vaccines",
        "Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs",
        "Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns",
        "Neutralizing antiviral B cell responses",
        "Specific cellular stimulation in the primary immune response: experimental test of a quantized model",
        "The influence of antigen organization on B cell responsiveness",
        "Insights into the trimeric HIV-1 envelope glycoprotein structure",
        "Advantages and prospects of Tag/Catcher mediated antigen display on capsid-like particle-based vaccines",
        "Interaction of viral capsid-derived virus-like particles (VLPs) with the innate immune system",
        "Innate immunity mediates follicular transport of particulate but not soluble protein antigen",
        "Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation",
        "Regulation of the germinal center response",
        "Bacteriophage and the innate immune system: access and signaling",
        "RNA and Toll-like receptor 7 license the generation of superior secondary plasma cells at multiple levels in a B cell intrinsic fashion",
        "B cells are the dominant antigen-presenting cells that activate naive CD4+ T cells upon immunization with a virus-derived nanoparticle antigen",
        "Type of RNA packed in VLPs impacts IgG class switching-Implications for an influenza vaccine design",
        "Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles",
        "Determinants of autoantibody induction by conjugated papillomavirus virus-like particles",
        "Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis",
        "Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer's and cat allergy",
        "New routes and opportunities for modular construction of particulate vaccines: stick, click, and glue",
        "Bacterial superglue enables easy development of efficient virus-like particle based vaccines",
        "Plug-and-display: decoration of virus-like particles via isopeptide bonds for modular immunization",
        "Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques",
        "Therapeutic potential of Toll-like receptor 9 activation",
        "Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial",
        "Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study",
        "The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma",
        "CYT003, a TLR9 agonist, in persistent allergic asthma -a randomized placebo-controlled Phase 2b study",
        "CD4+ T cells induced by virus-like particles expressing a major T cell epitope down-regulate IL-5 production in an ongoing immune response to Der p 1 independently of IFN-gamma production",
        "Immune response modulation by recombinant peptides expressed in virus-like particles",
        "Adeno-associated virus-like particles as new carriers for B-cell vaccines: testing immunogenicity and safety in BALB/c mice",
        "Modulation of allergen-specific T-lymphocyte function by virus-like particles decorated with HLA class II molecules",
        "Modular MLV-VLPs co-displaying ovalbumin peptides and GM-CSF effectively induce expansion of CD11b+ APC and antigen-specific T cell responses in vitro",
        "Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model",
        "Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy",
        "Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells",
        "Activation/inhibition of mast cells by supra-optimal antigen concentrations",
        "Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects",
        "Immunization of cats against Fel d 1 results in reduced allergic symptoms of owners",
        "Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens",
        "Virus-like particles displaying major house dust mite allergen Der p 2 for prophylactic allergen immunotherapy",
        "Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults",
        "The use of biologics for immune modulation in allergic disease",
        "Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice",
        "Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice",
        "A potential immunotherapy approach: mucosal immunization with an IL-13 peptide-based virus-like particle vaccine in a mouse asthma model",
        "Sustained suppression of IL-13 by a vaccine attenuates airway inflammation and remodeling in mice",
        "Targeting IL-23 by employing a p40 peptide-based vaccine ameliorates murine allergic skin and airway inflammation",
        "Virus-like particles presenting interleukin-33 molecules: immunization characteristics and potentials of blockingIL-33/ST2 pathway in allergic airway inflammation",
        "Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice",
        "Vaccination against IL-31 for the treatment of atopic dermatitis in dogs",
        "Treating insect-bite hypersensitivity in horses with active vaccination against IL-5",
        "Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses",
        "Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itch",
        "Interleukin-31 and interleukin-31 receptor: new therapeutic targets for atopic dermatitis",
        "New strategies for prevention and treatment of insect bite hypersensitivity in horses",
        "Safety profile of a virus-like particle-based vaccine targeting self-protein interleukin-5 in horses",
        "Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper",
        "A single monoclonal antibody against the peanut allergen Ara h 2 protects against systemic and local peanut allergy",
        "An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor Fc\u03b3RIIb",
        "Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines -recommendations on the use of biologicals in severe asthma",
        "Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn Academic Advancement",
        "Ratchadapisek Sompotch Fund",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}